Improving Pharmacokinetics Reducing In Blood Glucose By Glucagon-Like Peptide-1 Using Albumin-Binding Domain.
Sign Up to like & getrecommendations! Published in 2019 at "Current pharmaceutical biotechnology"
DOI: 10.2174/1389201021666200101105018
Abstract: OBJECTIVE Frequent administrations for DPPIV-resistant GLP-1 analogs are necessary to maintain the blood concentrations due to short half-life of less than 5 minutes. However, most delivery systems that harbor ability of sustainable release GLP-1 subject… read more here.
Keywords: delivery; reducing blood; blood; blood glucose ... See more keywords